| Primary |
| Hypertension |
30.0% |
| Blood Pressure |
20.0% |
| Dark Circles Under Eyes |
10.0% |
| Diabetes Mellitus |
10.0% |
| Hepatic Steatosis |
10.0% |
| Peripheral Vascular Disorder |
10.0% |
| Inflammation |
5.0% |
| Therapeutic Skin Care Topical |
5.0% |
|
| Blood Pressure Increased |
20.0% |
| Medication Error |
20.0% |
| Vision Blurred |
20.0% |
| Death |
10.0% |
| Poor Quality Drug Administered |
10.0% |
| Sinus Bradycardia |
10.0% |
| Swelling Face |
10.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
23.8% |
| Product Used For Unknown Indication |
15.0% |
| Pain |
9.8% |
| Ill-defined Disorder |
4.1% |
| Depression |
3.9% |
| Blood Pressure Increased |
3.4% |
| Constipation |
3.4% |
| Diabetes Mellitus |
3.4% |
| Fibromyalgia |
3.0% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Myalgia |
3.0% |
| Thyroid Disorder |
3.0% |
| Nasal Septum Deviation |
2.9% |
| Restless Legs Syndrome |
2.9% |
| Blood Pressure |
2.7% |
| Cardiac Disorder |
2.7% |
| Sleep Apnoea Syndrome |
2.7% |
| Blood Cholesterol Increased |
2.5% |
| Hiv Infection |
2.5% |
| Personality Disorder |
2.3% |
|
| Fibromyalgia |
24.6% |
| Vision Blurred |
7.7% |
| Vomiting |
6.2% |
| Pain |
4.6% |
| Periorbital Haemorrhage |
4.6% |
| Staphylococcal Infection |
4.6% |
| Tinnitus |
4.6% |
| Urticaria |
4.6% |
| White Blood Cell Count Decreased |
4.6% |
| Cardiac Arrest |
3.1% |
| Creutzfeldt-jakob Disease |
3.1% |
| Drug Ineffective |
3.1% |
| Dysuria |
3.1% |
| Interstitial Lung Disease |
3.1% |
| Mania |
3.1% |
| Nausea |
3.1% |
| Pneumothorax |
3.1% |
| Skin Exfoliation |
3.1% |
| Tremor |
3.1% |
| Weight Decreased |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.0% |
| Drug Use For Unknown Indication |
19.6% |
| Hypertension |
5.7% |
| Osteoporosis |
5.2% |
| Vitamin Supplementation |
4.2% |
| Pain |
3.5% |
| Rheumatoid Arthritis |
3.4% |
| Supplementation Therapy |
2.9% |
| Prophylaxis |
2.6% |
| Blood Cholesterol Increased |
2.6% |
| Osteopenia |
2.4% |
| Depression |
2.4% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Asthma |
1.7% |
| Diabetes Mellitus |
1.6% |
| Multiple Myeloma |
1.6% |
| Arthritis |
1.6% |
| Hepatitis C |
1.5% |
| Multiple Sclerosis |
1.5% |
| Parkinson's Disease |
1.3% |
|
| Weight Decreased |
15.8% |
| Vomiting |
11.1% |
| Weight Increased |
9.3% |
| Vision Blurred |
5.2% |
| Urinary Tract Infection |
4.8% |
| Nausea |
4.7% |
| Flushing |
4.6% |
| Death |
4.4% |
| Pain |
4.2% |
| Drug Ineffective |
4.1% |
| Pruritus |
3.9% |
| Rash |
3.7% |
| Urticaria |
3.6% |
| Paraesthesia |
3.3% |
| Pain In Extremity |
3.0% |
| Somnolence |
3.0% |
| Tremor |
3.0% |
| Pneumonia |
2.8% |
| Headache |
2.8% |
| Myocardial Infarction |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
43.1% |
| Drug Use For Unknown Indication |
27.5% |
| Systemic Candida |
7.8% |
| Blood Cholesterol |
3.9% |
| Anal Candidiasis |
2.0% |
| Breast Cancer |
2.0% |
| Cough |
2.0% |
| Lower Respiratory Tract Infection |
2.0% |
| Pneumonia |
2.0% |
| Supplementation Therapy |
2.0% |
| Thyroid Disorder |
2.0% |
| Tremor |
2.0% |
| Vulvovaginal Dryness |
2.0% |
|
| International Normalised Ratio Increased |
23.1% |
| Gastrointestinal Haemorrhage |
15.4% |
| Renal Disorder |
15.4% |
| Contusion |
7.7% |
| Drug Interaction |
7.7% |
| Haematoma |
7.7% |
| Tremor |
7.7% |
| Vomiting |
7.7% |
| Vulvovaginal Dryness |
7.7% |
|
